Shandong Boan Biotechnology Co., Ltd. (HKG:6955)
Hong Kong · Delayed Price · Currency is HKD 4.750
-0.150 (-3.06%)
Jun 18, 2026, 11:59 AM HKT
HKG:6955 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 7.14 | 73.19 | -119.38 | -331.75 | -225.42 |
Depreciation & Amortization | 51.98 | 44.96 | 59.45 | 57.35 | 40.63 |
Other Amortization | 35.84 | 27.95 | 23.31 | 15.48 | 9.38 |
Loss (Gain) From Sale of Assets | 0.2 | - | - | 0.02 | 0.07 |
Stock-Based Compensation | 13.37 | 21.5 | 20.64 | 18.48 | 21.28 |
Provision & Write-off of Bad Debts | 1.51 | 2.17 | -0.03 | 0.03 | - |
Other Operating Activities | 37.82 | 33.11 | 15.76 | 5.12 | 7.45 |
Change in Accounts Receivable | -219.19 | -179.58 | -60.21 | -104.88 | -106.57 |
Change in Inventory | 38.29 | -2.96 | -21.66 | -44.79 | -79.17 |
Change in Accounts Payable | -65.31 | -3.98 | 57.37 | 21.49 | 47.13 |
Change in Unearned Revenue | 21.7 | 2.34 | 3 | -1.8 | -1 |
Change in Other Net Operating Assets | 141.53 | -136.64 | 3.17 | 163.42 | 39.95 |
Operating Cash Flow | 64.89 | -117.94 | -18.57 | -201.84 | -246.28 |
Capital Expenditures | -72.55 | -66.6 | -67.32 | -81.29 | -107.73 |
Sale of Property, Plant & Equipment | - | 0.01 | - | - | - |
Sale (Purchase) of Intangibles | -201.49 | -296.31 | -227.43 | -125.09 | -233.52 |
Investment in Securities | - | - | - | 100 | -100 |
Other Investing Activities | - | - | 1.19 | 5.69 | 8.95 |
Investing Cash Flow | -274.05 | -362.89 | -293.57 | -100.68 | -432.3 |
Short-Term Debt Issued | - | 1.44 | 1.37 | - | 2.83 |
Long-Term Debt Issued | 360.83 | 421.92 | 132.85 | 52.98 | - |
Total Debt Issued | 360.83 | 423.36 | 134.22 | 52.98 | 2.83 |
Long-Term Debt Repaid | -258.19 | -147.08 | -37.03 | -18.61 | -9.43 |
Total Debt Repaid | -258.19 | -147.08 | -37.03 | -18.61 | -9.43 |
Net Debt Issued (Repaid) | 102.64 | 276.28 | 97.19 | 34.37 | -6.6 |
Issuance of Common Stock | 1,076 | 229.53 | - | 189.16 | 1,230 |
Other Financing Activities | -37.27 | -27.98 | 185.89 | -223.66 | -11.89 |
Financing Cash Flow | 1,141 | 477.83 | 283.09 | -0.13 | 1,212 |
Foreign Exchange Rate Adjustments | -0.21 | 0.01 | -2.6 | 4.45 | -5.08 |
Net Cash Flow | 931.54 | -2.98 | -31.65 | -298.21 | 528.07 |
Free Cash Flow | -7.66 | -184.53 | -85.89 | -283.13 | -354.01 |
Free Cash Flow Margin | -0.98% | -25.41% | -13.89% | -54.87% | -223.06% |
Free Cash Flow Per Share | -0.01 | -0.34 | -0.17 | -0.57 | -0.74 |
Cash Interest Paid | 37.27 | 27.98 | 14.11 | 13.05 | 11.6 |
Levered Free Cash Flow | -299.91 | -586.09 | -77.35 | -484.93 | -801.42 |
Unlevered Free Cash Flow | -275.75 | -565.68 | -68.55 | -476.55 | -794.17 |
Change in Working Capital | -82.98 | -320.81 | -18.33 | 33.44 | -99.66 |